Načítá se...
Do we want more cancer patients on clinical trials If so, what are the barriers to greater accrual
It is often stated that only a small proportion of adult cancer patients participate in clinical trials. This is said to be a bad thing, with calls for more trials to include more patients. Here I argue that whether or not greater accrual to clinical trials would be a good thing depends on the trial...
Uloženo v:
| Hlavní autor: | |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2008
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2429895/ https://ncbi.nlm.nih.gov/pubmed/18522732 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1745-6215-9-31 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|